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Previous studies have indicated that age is a risk factor for severe falciparum malaria in nonimmune patients.
The objectives of this study were to reevaluate previous findings with a larger sample and to find out how
strongly clinical outcomes for elderly patients differ from those for younger patients. Results of adjusted
analyses indicated that the risks of death due to falciparum malaria, of experiencing cerebral or severe disease
in general, and of hospitalization increased significantly with each decade of life. The case-fatality rate was
almost 6 times greater among elderly patients than among younger patients, and cerebral complications
occurred 3 times more often among elderly patients. Antimalarial chemoprophylaxis was significantly associated
with a lower case-fatality rate and a lower frequency of cerebral complications. Women were more susceptible
to cerebral complications than were men. Our study provides evidence that falciparum malaria is more serious
in older patients and demonstrates that clinical surveillance networks are capable of providing quality data
for investigation of rare events or diseases.
In regions of endemicity, severe Plasmodium falciparum
malaria is seen primarily in children [1, 2] . However,
several investigations involving nonimmune patients
have indicated that severe [3–7] or fatal cases [3, 4,
7–11] are more common in older patients. Against that
background, age-specific guidelines for treatment of fal-
ciparum malaria have become a matter of discussion.
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Because severe malaria is a rare event in countries
where it is not endemic, and because elderly patients
constitute only a small fraction of nonimmune patients
with malaria, data are sparse, which has hindered pre-
vious studies investigating the effect of age on disease
severity from applying statistical methods of con-
founder control. Clinical surveillance networks for im-
ported diseases, like the European TropNetEurop and
its German sister network, Surveillance importierter In-
fektionen in Deutschland (SIMPID) [12], receive data
on large numbers of malaria cases in nonimmune pa-
tients [13] from different age groups and, therefore,
provide a unique opportunity for studies on rare disease
events. The objectives of the present study were to reev-
aluate, with a larger sample size, the finding from pre-
vious, underpowered studies that age is a risk factor
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for severe falciparum malaria in nonimmune patients, and to
find out how strongly elderly patients (age, 60 years) differ
from younger patients (age, 10–59 years) with respect to disease
severity.
PATIENTS, MATERIALS, AND METHODS
The European network TropNetEurop and its German sister
network, SIMPID, are designed to effectively detect emerging
infections of potential regional, national, or global impact at
their point of entry into the domestic population, to link clinical
and epidemiological knowledge, and to serve as research plat-
forms. Both networks are closely connected by common or-
ganizational and technical structures and identical reporting
procedures. Surveillance reporting is performed by clinical
member sites using a computerized reporting system. Electronic
transmission of anonymous case information, comprising stan-
dardized demographic, epidemiological, and clinical data, to
the central database assures rapid detection of sentinel events.
Network membership is self-selected, and the network does not
guarantee representative data collection for Europe. However,
most major referral centers in Europe are represented (infor-
mation is available at http://www.tropnet.net/ and http://www.
simpid.de).
We conducted an observational study that involved patients
with falciparum malaria reported to TropNetEurop and SIM-
PID during the period of January 1999 through July 2002. Data
from both networks were pooled to increase statistical power.
Included in the present analysis were data on Europeans re-
turning to Europe with falciparum malaria. Excluded were data
on cases involving immigrants, foreign visitors, expatriates, pa-
tients with mixed plasmodial or other concomitant infections,
and children !10 years of age. Children and patients with con-
comitant infections were excluded to reduce baseline hetero-
geneity in the study population.
The influence of age on manifestations and outcome of se-
vere disease was analyzed in crude and adjusted logistic re-
gression models. Age was studied in an ordinal model, to in-
vestigate whether the risk for severe disease increases by decade
of life, and in a dichotomous model, to compare elderly patients
(age, 60 years) with younger patients (age, 10–59 years). The
investigated outcomes of severe disease were mortality, cerebral
complications (as defined by World Health Organization cri-
teria [1]), overall complications, and rate of hospitalization.
Risk factors for severe disease are likely to be unevenly dis-
tributed in an international survey population. Therefore, con-
trol for confounding variables may be an important issue in
the estimation of unbiased age effects. The potential confound-
ing variables considered in our analyses were sex, receipt of
chemoprophylaxis, region where infection occurred, travel pur-
pose, country where infection was notified, and time from onset
of infection to receipt of treatment. Covariate selection for
adjusted analyses was performed by backward elimination at a
5% a level. Multivariate analysis was done for each outcome
to choose variables for adjusted analyses. All analyses were done
with use of SAS software, release 8.01 (SAS Institute).
RESULTS
From January 1999 through July 2002, a total of 3028 patients
with imported cases of falciparum malaria were reported to the
TropNetEurop and SIMPID databases; 179 patients (5.9%) were
60 years of age. A total of 1270 (41.9%) of the infections
were imported by European nationals who were presently living
and working in Europe; 78 (6.1%) of the affected patients were
aged 60 years. Further exclusion of patients with mixed in-
fection, patients with multiple infections, and children aged
!10 years resulted in a study population of 1181 patients.
Table 1 presents baseline characteristics of the study popu-
lation. Patients were reported from 15 European countries, with
Germany, the United Kingdom, Spain, and France contributing
the bulk of patient data. Poland, Switzerland, Italy, Belgium,
and Denmark contributed more-than-proportional numbers of
elderly patients, compared with their overall case contribution.
Nine of 10 patients were infected in Africa, mostly in the west-
ern region. Eastern and central Africa and the Madagascar re-
gion contributed more-than-proportional numbers of cases in
elderly patients. Tourism, visits to relatives and friends, and
business travel were the most frequent reasons for travel. Com-
pared with younger patients, elderly patients traveled less often
for tourist- or business-related reasons but more often for hu-
manitarian reasons. Approximately two-thirds of the patients
were male. Among elderly patients, the proportion of men was
even higher. Receipt of pretravel advice and antimalarial che-
moprophylaxis was more common among older patients. No
differences were found with respect to travel duration and time
from the onset of symptoms to presentation. Heterogeneity of
the older and younger age groups could be confirmed at the
5% a level only for sex and prophylaxis. However, testing for
heterogeneity of highly multidimensional characteristics, such
as reporting country or region where infection occurred, may
have failed to yield significant results as a result of limited
statistical power.
The age range of patients in our study was 10–81 years. Age-
specific frequencies of outcomes of severe disease are presented
in table 2. Altogether, 113 cases (9.6%) of severe malaria were
observed, consisting of 37 cases (3.1%) involving cerebral man-
ifestations and 76 cases (6.4%) involving other severe or com-
plicated manifestations. Seventeen patients with severe disease
died, yielding a case-fatality rate of 1.4%. Eleven of the severe
Table 1. Baseline characteristics of patients in a study of falciparum malaria.
Characteristic
Patient group
All
(n p 1181)
Aged
60 years
(n p 78)
Aged
10–59 years
(n p 1103)
Time to treatment, median days (IQR)a 4 (2–7) 4 (2–6) 4 (2–7)
Sexb
No data — 5 (0.5) 5 (0.4)
Male 62 (79.5) 700 (63.5) 762 (64.5)
Female 16 (20.5) 398 (36.1) 414 (35.1)
Received pretravel advice
No data 31 (39.7) 526 (47.7) 557 (47.2)
Yes 28 (35.9) 285 (25.8) 313 (26.5)
No 19 (24.4) 292 (26.5) 311 (26.3)
Received prophylaxisb
No data 7 (9.0) 76 (6.9) 83 (7.0)
Yes 38 (48.7) 416 (37.7) 454 (38.4)
No 33 (42.3) 611 (55.4) 644 (54.5)
Travel purpose
No data 5 (6.4) 31 (2.8) 36 (3.0)
Tourism 43 (55.1) 666 (60.4) 709 (60.0)
Visiting friends and/or relatives 12 (15.4) 157 (14.2) 169 (14.3)
Business 9 (11.5) 157 (14.2) 166 (14.1)
Missionary/humanitarian 9 (11.5) 42 (3.8) 51 (4.3)
Other 0 (0) 50 (4.6) 50 (4.3)
Region where infection occurred
No data — 1 (0.1) 1 (9.7)
Africa
Central 10 (12.8) 104 (9.4) 114 (9.7)
Eastern 23 (29.5) 169 (15.3) 192 (16.3)
Northern — 3 (0.3) 3 (0.3)
Southern 2 (2.6) 97 (8.8) 99 (8.4)
Western 38 (48.7) 615 (55.8) 653 (55.3)
Other 5 (6.4) 114 (10.4) 119 (10.1)
Country where infection was reported
Austria 2 (2.6) 41 (3.7) 43 (3.6)
Belgium 10 (12.8) 73 (6.6) 83 (7.0)
Czech Republic 1 (1.3) 27 (2.4) 28 (2.4)
Denmark 11 (14.1) 88 (8.0) 99 (8.4)
France 7 (9.0) 120 (10.9) 127 (10.8)
Germany 18 (23.1) 369 (33.5) 387 (32.8)
Ireland — 5 (0.5) 5 (0.4)
Italy 4 (5.1) 22 (2.0) 26 (2.2)
Norway — 5 (0.5) 5 (0.4)
Poland 2 (2.6) 7 (0.6) 9 (0.8)
Portugal — 6 (0.5) 6 (0.5)
Spain 7 (9.0) 124 (11.2) 131 (11.1)
Sweden — 19 (1.7) 19 (1.6)
Switzerland 5 (6.4) 18 (1.6) 23 (1.9)
United Kingdom 11 (14.1) 179 (16.2) 190 (16.1)
NOTE. Data are no. (%) of patients, unless otherwise indicated. IQR, interquartile range.
a Time from onset of symptoms.
b Significant group heterogeneity occurred at the 5% a level
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Table 2. Age-specific frequency of outcomes of severe falci-
parum malaria.
Age
group,
years
No. of
patients
Percentage of patients with
Fatal
cases
Cerebral
complications
Overall
complications
Hospital
admissiona
10–19 50 0.0 0.0 4.0 70.0
20–29 290 0.7 1.0 6.2 79.0
30–39 369 0.5 1.9 7.3 79.7
40–49 225 2.2 6.2 13.8 81.8
50–59 169 2.4 4.7 14.2 85.2
60–69 56 3.6 5.4 8.9 73.2
70–79 20 10.0 10.0 30.0 95.0
80–89 2 0.0 0.0 0.0 100.0
Total 1181 1.4 3.1 9.6 80.3
a Values are missing for 39 patients.
Table 3. Crude and adjusted effect of age on different out-
comes of Plasmodium falciparum infection in European
patients.
Outcome,
age model
OR (95% CI)
Crude
analysis
Adjusted
analysis
Death
Per decade 1.73 (1.25–2.38) 1.85 (1.30–2.62)a
Old vs. young 4.53 (1.44–14.24) 5.74 (1.78–18.47)a
Cerebral complications
Per decade 1.53 (1.22–1.92) 1.66 (1.31–2.12)b
Old vs. young 2.29 (0.87–6.06) 3.29 (1.20–9.01)b
Overall complications
Per decade 1.33 (1.16–1.52) 1.32 (1.14–1.53)c
Old vs. young 1.61 (0.83–3.15) 1.64 (0.81–3.30)c
Hospitalization
Per decade 1.13 (1.00–1.27) 1.21 (1.06–1.39)d
Old vs. young 0.97 (0.53–1.81) 1.30 (0.64–2.63)d
NOTE. Old, age of 60 years; young, age of 10–59 years.
a Adjusted for prior receipt of antimalarial chemoprophylaxis.
b Adjusted for prior receipt of antimalarial chemoprophylaxis and sex.
c Adjusted for notifying country.
d Adjusted for sex and notifying country.
cases and 4 of the fatal cases involved elderly patients (age,
60 years). The overall hospitalization rate was 80.3%; how-
ever, information on care status was not available for 39
patients.
Table 3 summarizes the ORs and 95% CIs for the age-out-
come associations derived from crude and adjusted logistic
models. The effect of age on the frequency of certain outcomes
was estimated twice for each outcome. First, we quantified the
risk increase per additional decade of life, and, second, we
quantified the risk for elderly patients compared with younger
patients. As expressed by the adjusted OR, the risk of death
due to falciparum malaria increased by ∼85% per decade of
life (OR, 1.85; 95% CI, 1.30–2.62). The case-fatality rate for
older patients was ∼6 times higher than that for younger pa-
tients (OR, 5.74; 95% CI, 1.78–18.47). The risk of developing
cerebral complications increased by ∼65% per decade of life
(OR, 1.66; 95% CI, 1.31–2.12), and elderly patients had a 3-
fold higher risk than did patients in the younger age group
(OR, 3.29; 95% CI, 1.20–9.01). Prior receipt of antimalarial
chemoprophylaxis was found to significantly reduce the risk of
death due to disease (OR, 0.17; 95% CI, 0.04–0.74) or of de-
velopment of cerebral complications (OR, 0.44; 95% CI,
0.20–0.96). Women had more than twice the risk of developing
cerebral complications compared with men (OR, 2.63; 95% CI,
1.33–5.20).
The risk of developing severe disease in general was found
to increase by ∼30% per decade of life (OR, 1.32; 95% CI,
1.14–1.53). However, elderly patients were compared with
younger patients by Student’s t test, and only a nonsignificant
result was attained (OR, 1.64; 95% CI, 0.81–3.30).
The frequency of hospital admission also was found to in-
crease with each decade of life (OR, 1.21; 95% CI, 1.06–1.39),
whereas dichotomous comparison again only indicated a non-
significant elevated risk for elderly patients (OR, 1.30; 95% CI,
0.64–2.67). It should be noted that adjustment for notifying
country evened out imbalances that resulted from country-
specific admission preferences. For example, most patients who
notified the networks from Ireland, Switzerland, and Belgium
received outpatient treatment, whereas patients who notified
the network from other countries were more often hospitalized.
Women more often received inpatient treatment than did men
(OR, 2.02; 95% CI, 1.36–2.99). Length of inpatient hospital
stay was considered to be a possible indicator for disease se-
verity, too. However, because it was an optional surveillance
parameter, data were available for only 179 patients, 15 of
whom were from the old age group and 164 of whom were
from the younger age group. Analysis of this subset of patients
indicated that 50% of the hospitalized patients aged 60 years
spent 7 days (interquartile range, 4–10 days) in the hospital,
whereas, for the younger age group, the median duration of
inpatient stay was only 5 days (interquartile range, 4–7 days).
However, because of the limited sample size used in the su-
banalysis, this finding may be a result of chance ( ).Pp .1297
DISCUSSION
Several investigations have indicated that older age is a risk
factor for severe [3–7] or fatal falciparum malaria [3, 4, 7–11]
in nonimmune patients. However, because severe malaria is a
rare finding when patients are treated in a timely manner, and
because elderly patients account only for a minor fraction of
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nonimmune patients with malaria, previous analyses were con-
siderably impaired by limited sample size. The objective of the
present study was to reevaluate the findings from previous in-
vestigations in adjusted analyses that control for potential con-
founding variables and to determine how greatly the clinical
course in elderly patients aged 60 years differs from that in
younger patients. Comparison of the number of severe cases
included in the present study with data from former studies
confirms that clinical surveillance networks like TropNetEurop
and SIMPID are highly capable of providing superior data for
studies on rare disease-associated events.
Data analyses yielded significant results, demonstrating that
the risks of death due to falciparum malaria (OR, 1.85; 95%
CI, 1.30–2.62), of experiencing cerebral (OR, 1.66; 95% CI,
1.31–2.12) or severe disease in general (OR, 1.32; 95% CI,
1.14–1.53), and of hospitalization (OR, 1.21; 95% CI, 1.06–
1.39) increased with each decade of life. Prior receipt of an-
timalarial chemoprophylaxis was significantly associated with
a lower case-fatality rate (OR, 0.17; 95% CI, 0.04–0.74) and
with a lower frequency of cerebral complications (OR, 0.44;
95% CI, 0.20–0.96). Women were found to have a higher risk
of developing cerebral complications (OR, 2.63; 95% CI,
1.33–5.20) than were men. However, it should be noted that
we did not perform systematic risk factor analyses to study the
effects of receipt of chemoprophylaxis and sex. We found that
the case-fatality rate and the risk of developing severe disease
in general increase with age, which is basically consistent with
the findings from previous unadjusted or less-extensive analyses
[3–11], although a quantitative comparison of the findings is
impossible to perform because of methodological differences
between analyses. To our knowledge, the effect of age on the
occurrence of cerebral complications has not previously been
analyzed separately in nonimmune patients, although cerebral
malaria has been reported as a manifestation of severe disease
in previous studies [4, 5, 7].
To date, elderly patients (age, 60 years) have been com-
pared with younger patients only in a recent Danish case-con-
trol study [6]. However, that study included only 2 cases of
severe disease. Our comparison provides significant evidence
that the risk of death due to falciparum malaria (OR, 5.74;
95% CI, 1.78–18.47) and of development of cerebral compli-
cations (OR, 3.29; 95% CI, 1.20–9.01) is several times higher
among elderly, nonimmune patients. OR estimates from ad-
justed analyses also indicated that there were higher risks for
severe disease in general and for hospitalization. However, the
differences in risk were more subtle and could not be confirmed
statistically, which may be explained by power limitations re-
lated to the high age cutoff applied in our study. Power limi-
tations caused by missing values might have prevented statistical
confirmation of prolonged duration of inpatient hospital stay
observed in elderly patients.
The results of the present study confirm that the risks of
death and development of severe complications due to falci-
parum malaria increase with age in nonimmune patients. But
how can it be explained that, in nonimmune populations, severe
malaria is more often seen in older patients, whereas, in semi-
immune populations, severe malaria is a problem among
younger persons? One explanation might be that our analysis
could be confounded. However, because neither adjustment for
receipt of chemoprophylaxis or treatment delay nor adjustment
for other potential confounding variables reversed the direction
of the detected age-outcome associations, we consider con-
founding an unlikely explanation. Another explanation might
be that our findings only reflect higher background mortality
and a more-fragile health state among persons in older age
groups. However, data analyses in this investigation detected a
continuous risk increase over the whole age spectrum, whereas
the risk for severe disease was shown to decrease with age in
a semi-immune population [2]. Thus, this explanation is most
likely insufficient. A more convincing explanation might be that
our findings reflect a decreasing capability of the aging immune
system to mount defensive responses against previously unen-
countered infectious agents. This hypothesis is supported by
findings of Gjørup and Rønn [6], who detected significantly
higher rates of parasitemia in elderly, nonimmune patients. It
would also be consistent with the observation that people in
areas of endemicity who are regularly exposed to plasmodia are
not at higher risk of developing complications when they get
older. Another explanation, which centers on age-specific im-
mune responses, was given by Baird et al. [3], who hypothesized
that the balance between protective and harmful immune re-
sponses might shift towards the harmful side with increasing
age. Again, to be consistent with the different risk situation in
areas of endemicity, this shift would have to be more pro-
nounced in previously unchallenged hosts. In general, elderly
patients experience increased susceptibility to and morbidity
associated with many infectious diseases, mostly due to com-
orbidity [14, 15]. Presumably, a decreased ability to mount an
adequate immune response plays an important additional role.
Results from various studies indicate a shift from Th1 to Th2
response with increasing age, among other responses, leading
to decreased cellular response [16, 17]. The main mechanisms
of early host response to plasmodial infection are not well
elucidated.
It remains to be studied whether there is a connection be-
tween the immunological response to malaria and age-related
changes in the immune system. To uncover the pathophysio-
logical mechanisms behind the findings of this study will be
an objective for future investigations. The finding that female
sex was associated with a higher risk of cerebral complications
might trigger further research, too.
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